2018-19 Section 7-Neoplastic and Inflammatory Diseases of the Head and Neck eBook

Original Article

11. Wong KS, Angell TE, Strickland KC, et al. Noninvasive follicular variant of papillary thyroid carcinoma and the Afirma gene- expression classifier. Thyroid . 2016;26:911-915. 12. Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thy- roid Cytopathology. Thyroid . 2017;27:1341-1346. 13. Hang JF, Westra WH, Cooper DS, Ali SZ. The impact of nonin- vasive follicular thyroid neoplasm with papillary-like nuclear fea- tures on the performance of the Afirma gene expression classifier. Cancer Cytopathol . 2017;125:683-691. 14. Samulski TD, LiVolsi VA, Wong LQ, Baloch Z. Usage trends and performance characteristics of a “gene expression classifier” in the management of thyroid nodules: an institutional experience. Diagn Cytopathol . 2016;44:867-873. 15. Valderrabano P, Khazai L, Leon ME, et al. Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology. Endocr Relat Cancer . 2017;24:127-136. 16. Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: A paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016; doi: 10.1001/jamaoncol.2016.0386. 17. Jiang XS, Harrison GP, Datto MB. Young Investigator Challenge: molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Cancer Cytopathol . 2016;124: 893-900. 18. Parente DN, Kluijfhout WP, Bongers PJ, et al. Clinical safety of renaming encapsulated follicular variant of papillary thyroid carci- noma: is NIFTP truly benign? World J Surg . 2018;42:321-326. 19. Baloch ZW, Harrell RM, Brett EM, Randolph G, Garber JR; AACE Endocrine Surgery Scientific Committee and Thyroid Scien- tific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Commen- tary: Managing Thyroid Tumors Diagnosed as Noninvasive Follic- ular Thyroid Neoplasm with Papillary-Like Nuclear Features. Endocr Pract 2017;23:1150-1155.

2. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thy- roid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid . 2016;26:1-133. 3. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspi- ration: experience from an academic center using terminology simi- lar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol . 2009;117:195-202. 4. Bartolazzi A, Orlandi F, Saggiorato E, et al; Italian Thyroid Cancer Study Group (ITCSG). Galectin-3-expression analysis in the surgi- cal selection of follicular thyroid nodules with indeterminate fine- needle aspiration cytology: a prospective multicentre study. Lancet Oncol . 2008;9:543-549. 5. Jooya A, Saliba J, Blackburn A, et al. The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules. J Otolaryngol Head Neck Surg . 2016;45:51. 6. Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologi- cally indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab . 2011;96:3390-3397. 7. Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diag- nosis of benign thyroid nodules with indeterminate cytology. N Engl J Med . 2012;367:705-715. 8. Harrison G, Sosa JA, Jiang X. Evaluation of the Afirma gene expression classifier in repeat indeterminate thyroid nodules. Arch Pathol Lab Med . 2017;141:985-989. 9. Faquin WC, Wong LQ, Afrogheh AH, et al. Impact of reclassify- ing noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thy- roid Cytopathology. Cancer Cytopathol . 2016;124:181-187. 10. Strickland KC, Howitt BE, Marqusee E, et al. The impact of non- invasive follicular variant of papillary thyroid carcinoma on rates of malignancy for fine-needle aspiration diagnostic categories. Thyroid . 2015;25:987-992.

Cancer Cytopathology

162